Literature DB >> 17561358

Identification and characterization of complete RTX operons in Moraxella bovoculi and Moraxella ovis.

John A Angelos1, Louise M Ball, John F Hess.   

Abstract

To determine if Moraxella bovoculi (M. bovoculi), a recently characterized coccoid Moraxella that was isolated from the eyes of calves affected with infectious bovine keratoconjunctivitis (IBK), and Moraxella ovis (M. ovis), originally isolated from sheep with conjunctivitis, possessed genes encoding RTX proteins, genomic DNA was amplified with oligonucleotide primers targeting RTX operon genes of Moraxella bovis (M. bovis). Complete classical RTX operons composed of RTXCABD genes closely linked to a putative secretion accessory protein encoding gene (tolC) were identified in M. bovoculi and M. ovis and were designated mbvCABDtolC and movCABDtolC, respectively. These genes were closely related to M. bovis mbxCABDtolC. Polyclonal rabbit antiserum against the carboxy terminus of M. bovoculi MbvA neutralized hemolytic activity of both M. bovoculi and M. ovis; this antiserum did not neutralize the hemolytic activity of M. bovis. M. bovoculi and M. ovis possess genes that encode proteins related to pathogenic factors of M. bovis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561358     DOI: 10.1016/j.vetmic.2007.05.009

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Whole genome sequencing of Moraxella bovis strains from North America reveals two genotypes with different genetic determinants.

Authors:  Emily L Wynn; Matthew M Hille; John Dustin Loy; Gennie Schuller; Kristen L Kuhn; Aaron M Dickey; James L Bono; Michael L Clawson
Journal:  BMC Microbiol       Date:  2022-10-21       Impact factor: 4.465

2.  Recombinant Moraxella bovoculi cytotoxin-ISCOM matrix adjuvanted vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.

Authors:  John A Angelos; V Michael Lane; Louise M Ball; John F Hess
Journal:  Vet Res Commun       Date:  2010-03-10       Impact factor: 2.459

3.  Relatedness of type IV pilin PilA amongst geographically diverse Moraxella bovoculi isolated from cattle with infectious bovine keratoconjunctivitis.

Authors:  John A Angelos; Kristin A Clothier; Regina L Agulto; Boguslav Mandzyuk; Morten Tryland
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

4.  Large genomic differences between Moraxella bovoculi isolates acquired from the eyes of cattle with infectious bovine keratoconjunctivitis versus the deep nasopharynx of asymptomatic cattle.

Authors:  Aaron M Dickey; John D Loy; James L Bono; Timothy P L Smith; Mike D Apley; Brian V Lubbers; Keith D DeDonder; Sarah F Capik; Robert L Larson; Brad J White; Jochen Blom; Carol G Chitko-McKown; Michael L Clawson
Journal:  Vet Res       Date:  2016-02-13       Impact factor: 3.683

5.  A 2-year randomized blinded controlled trial of a conditionally licensed Moraxella bovoculi vaccine to aid in prevention of infectious bovine keratoconjunctivitis in Angus beef calves.

Authors:  Annette O'Connor; Vickie Cooper; Laura Censi; Ella Meyer; Mac Kneipp; Grant Dewell
Journal:  J Vet Intern Med       Date:  2019-10-12       Impact factor: 3.333

6.  MALDI-TOF MS Biomarker Detection Models to Distinguish RTX Toxin Phenotypes of Moraxella bovoculi Strains Are Enhanced Using Calcium Chloride Supplemented Agar.

Authors:  Matthew M Hille; Michael L Clawson; Aaron M Dickey; Justin H Lowery; John Dustin Loy
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

7.  Draft Genome Sequence of Moraxella bovoculi Strain 237T (ATCC BAA-1259T) Isolated from a Calf with Infectious Bovine Keratoconjunctivitis.

Authors:  Michael J Calcutt; Mark F Foecking; Neal T Martin; Tendai Mhlanga-Mutangadura; Thomas J Reilly
Journal:  Genome Announc       Date:  2014-06-26

8.  Cervid herpesvirus 2 and not Moraxella bovoculi caused keratoconjunctivitis in experimentally inoculated semi-domesticated Eurasian tundra reindeer.

Authors:  Morten Tryland; Javier Sánchez Romano; Nina Marcin; Ingebjørg Helena Nymo; Terje Domaas Josefsen; Karen Kristine Sørensen; Torill Mørk
Journal:  Acta Vet Scand       Date:  2017-04-24       Impact factor: 1.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.